IHAM
Integral Health Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4M | Buy |
+115,000
| New | +$17.4M | 1.6% | 21 |
|
|
2024
Q2 | – | Sell |
-65,000
| Closed | -$17.6M | – | 81 |
|
|
2024
Q1 | $17.6M | Hold |
65,000
| – | – | 1.63% | 21 |
|
|
2023
Q4 | $15.4M | Buy |
+65,000
| New | +$15.4M | 2.09% | 13 |
|
|
2021
Q2 | – | Sell |
-35,000
| Closed | -$10.1M | – | 77 |
|
|
2021
Q1 | $10.1M | Sell |
35,000
-18,000
| -34% | -$5.22M | 2.9% | 9 |
|
|
2020
Q4 | $13.2M | Buy |
53,000
+20,000
| +61% | +$5M | 3.94% | 6 |
|
|
2020
Q3 | $7.47M | Sell |
33,000
-22,000
| -40% | -$4.98M | 2.29% | 14 |
|
|
2020
Q2 | $9.59M | Buy |
+55,000
| New | +$9.59M | 2.87% | 6 |
|